Clinical trials
Recruiting Infections trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
230 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2002 | 2 |
| 2004 | 1 |
| 2005 | 1 |
| 2006 | 1 |
| 2007 | 1 |
| 2010 | 2 |
| 2012 | 1 |
| 2013 | 1 |
| 2014 | 4 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 2 |
| 2019 | 2 |
| 2020 | 7 |
| 2021 | 15 |
| 2022 | 24 |
| 2023 | 25 |
| 2024 | 38 |
| 2025 | 55 |
| 2026 | 41 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 230 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Institute of Allergy and Infectious Diseases (NIAID) | 10 |
| Assistance Publique - Hôpitaux de Paris | 5 |
| Monash University | 5 |
| Murdoch Childrens Research Institute | 5 |
| Hospices Civils de Lyon | 3 |
| Institut Pasteur | 3 |
| Association Clinique Thérapeutique Infantile du val de Marne | 2 |
| AstraZeneca | 2 |
| AusperBio Therapeutics Inc. | 2 |
| BioNTech SE | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Infections | 230 |
| Sepsis | 17 |
| Virus Diseases | 17 |
| Neoplasms | 13 |
| Respiratory Tract Infections | 12 |
| Inflammation | 11 |
| COVID-19 | 10 |
| Communicable Diseases | 10 |
| Bacterial Infections | 9 |
| Pneumonia | 9 |
Trials
Showing 76 to 100 of 230. Each trial links to its page on Pharma Observatory.
130 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.